Overview
Saba Zamani’s practice encompasses multiple areas of intellectual property (IP) litigation, primarily in matters involving life sciences, medical devices, pharmaceuticals, and consumer products. Saba harnesses her background in science, technology, business, and their intersections to represent clients across a broad range of sectors.
Prior to law school, Saba worked at a healthcare services company, where she processed and assembled medical devices and conducted performance testing and data analysis. Saba also worked at an international IP solutions and services provider, gaining an in-depth understanding of IP prosecution and portfolio maintenance and collaborating with law firms and companies to tailor IP management software to their needs throughout the IP lifecycle.
During law school, Saba joined her knowledge and experience in IP matters with a deep understanding of business law. Saba was Vice President of the UC Davis Business Law Society, worked as a Research Assistant to Professor Menesh Patel on antitrust, securities, and corporate law matters, served as Articles Selection Editor on the UC Davis Business Law Journal, and centered much of her studies on business and tax law.
Saba’s multifaceted experience enriches her practice, enabling her to guide clients through the complex landscape of IP matters and the legal and commercial considerations that surround them.
Education
- University of California - Davis - School of Law (J.D., 2025), Business Law Certificate, Pro Bono Certificate
- Santa Clara University (B.S. Biology, 2021), cum laude, Minor in Biotechnology
Affiliations
Iranian American Bar Association
News & Insights
Articles
Sheila Swaroop and Saba Zamani, “What the ITC’s Zync v BMW decision means for section 337 litigants,” IAM, August 26, 2026.
Litigation Blog
Medical Device Blog